MAT
51
-3
MCD
67
2
RRC
56
4
CMG
51
-3
MOS
19
-4
PDCO
54
-4
PSX
40
-4
GOOGL
56
2
PG
51
3
AME
57
-2
UA
32
8
GPC
37
-14
EIX
69
3
AEP
58
2
TGT
50
-2
SLB
53
-3
PCAR
50
-3
PPG
61
-5
FCX
53
-5
DHI
53
-3
MAT
51
-3
MCD
67
2
RRC
56
4
CMG
51
-3
MOS
19
-4
PDCO
54
-4
PSX
40
-4
GOOGL
56
2
PG
51
3
AME
57
-2
UA
32
8
GPC
37
-14
EIX
69
3
AEP
58
2
TGT
50
-2
SLB
53
-3
PCAR
50
-3
PPG
61
-5
FCX
53
-5
DHI
53
-3
Financhill
Back

Touchstone Strategic Income Opports ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
26

SIO
Touchstone Strategic Income Opports ETF

Last Price:
26.50
Seasonality Move:
2.18%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
26
Touchstone Strategic Income Opports ETF (SIO) is a Sell

Is Touchstone Strategic Income Opports ETF a Buy, Sell or Hold?

  • The current Touchstone Strategic Income Opports ETF [SIO] share price is $26.54. The Score for SIO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • SIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SIO Stock Price Chart

What is Touchstone Strategic Income Opports ETF's stock price today?

  • The Touchstone Strategic Income Opports ETF share price today is $26.54
    The current trend is moderately bullish and SIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 74.16 Buy
Chaikin Money Flow: 1400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.17 - 26.45) Buy
Bollinger Bands (100): (25.2 - 26.12) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.48 Buy
20-day SMA: 26.35 Buy
50-day SMA: 26.06 Buy
200-day SMA: 25.42 Buy
8-day EMA: 26.48 Buy
20-day EMA: 26.36 Buy
50-day EMA: 26.09 Buy
200-day EMA: 25.46 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Touchstone Strategic Income Opports ETF Earnings Growth & SIO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Touchstone Strategic Income Opports ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):